Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
due to continuous improvements, product packaging may vary slightly
The coverage gap exacerbates health inequities: obesity disproportionately affects lower-income and minority populations who rely on public insurance
How Retatrutide Compares to Other Weight Loss Medications The Triple Agonist Advantage Retatrutide's unprecedented efficacy stems from its unique mechanism as a triple hormone receptor agonist , activating three complementary pathways: GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows gastric emptying, improves insulin secretion GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances GLP-1 effects, improves insulin sensitivity, may affect fat metabolism Glucagon: Increases energy expenditure, promotes fat burning, may improve metabolic rate Head-to-Head Comparison Retatrutide's 6.2 percentage point improvement over tirzepatide and 13.7 percentage point improvement over semaglutide represents a substantial therapeutic advance
When clinically appropriate, our Chandler providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program
US$ 20.21
US$ 25.00
US$ 24.54
US$ 22.15
US$ 27.40
US$ 25.51
US$ 28.63
US$ 28.36
